Prognostic relevance of targets used in antibody-drug conjugates in early breast cancer
Laufzeit: 01.01.2024 - 31.12.2028
imported
Kurzfassung
Prognostic assessment of potential targets (e.g., HER2, Trop1, Nectin-4) in a well-charaterized cohort of early breast cancer patients with long-term follow-up using Affymetrix HG U133.
Veröffentlichungen
- Schroeder, Maria; Schmidt, Marcus; Marme, Frederik
- Antibody-drug conjugates in metastatic breast cancer. A promising treatment strategy
